Takeaways: The licensing of Alethia CMV gives Meridian a saliva-based, rapid molecular test for congenital CMV that can be deployed in the hours after birth, shifting detection from delayed or i...
Browsing Tag: point of care molecular testing
Takeaways: The licensing of Alethia CMV gives Meridian a saliva-based, rapid molecular test for congenital CMV that can be deployed in the hours after birth, shifting detection from delayed or i...